Connect
MJA
MJA

Transcranial magnetic stimulation: an item number is justified

Saxby Pridmore
Med J Aust 2018; 208 (11): 468. || doi: 10.5694/mja17.00849
Published online: 18 June 2018

Evidence shows that transcranial magnetic stimulation is a safe and effective treatment for drug-resistant depression

Depression is the leading cause of disability globally.1 The condition is painful for the patient (and may end in suicide), distressing for relatives and friends and challenging to clinicians. One-third of patients with depression do not respond to the first antidepressant medication, the likelihood of achieving remission diminishes with each additional medication, and one-third will not respond to any known medication.2

  • Saxby Pridmore

  • University of Tasmania, Hobart, TAS

Correspondence: s.pridmore@utas.edu.au

Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.